1999
DOI: 10.1192/pb.23.6.339
|View full text |Cite
|
Sign up to set email alerts
|

Use of high-dose depot neuroleptics

Abstract: Aims and methodsTo identify and reduce the number of patients receiving depot neuroleptics above the British National Formulary maximum. The medical records were scrutinised and individual consultants were informed of the results.ResultsFor the team involved in this audit there was a significant reduction in the prescription of high-dose depot medication, but this did not generalise to other teams.Clinical implicationsDifferent teams should repeat the audit and a new depot card has been developed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2002
2002
2004
2004

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 8 publications
0
0
0
Order By: Relevance